Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Vaccination Against COVID-19 in Brazil: Case-Control Study

NCT05621928 is registered in ClinicalTrials.gov with The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) as lead sponsor.

NCT NCT05621928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Vaccination Against COVID-19 in Brazil: Case-Control Study
Lead sponsor
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Phase
Observational
Overall status
Unknown status
Start date
February 7, 2022
Completion date
December 30, 2024
Enrollment
3,920 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccines